WO2007003389A3 - Substituierte sulfolanylpyrazole und ihre verwendung - Google Patents
Substituierte sulfolanylpyrazole und ihre verwendung Download PDFInfo
- Publication number
- WO2007003389A3 WO2007003389A3 PCT/EP2006/006430 EP2006006430W WO2007003389A3 WO 2007003389 A3 WO2007003389 A3 WO 2007003389A3 EP 2006006430 W EP2006006430 W EP 2006006430W WO 2007003389 A3 WO2007003389 A3 WO 2007003389A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- sulfolanyl
- pyrazoles
- substituted
- diseases
- prophylaxis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- AIDS & HIV (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Die vorliegende Erfindung betrifft neue substituierte Sulfola- nylpyrazole, Verfahren zu ihrer Herstellung, ihre Verwendung zur Behandlung und/oder Prophylaxe von Krankheiten sowie ihre Verwendung zur Herstellung von Arzneimitteln zur Behandlung und/oder Prophylaxe von Krankheiten, insbesondere von retrovi- ralen Erkrankungen, bei Menschen und/oder Tieren.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005031580A DE102005031580A1 (de) | 2005-07-06 | 2005-07-06 | Substituierte Sulfolanylpyrazole und ihre Verwendung |
DE102005031580.1 | 2005-07-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007003389A2 WO2007003389A2 (de) | 2007-01-11 |
WO2007003389A3 true WO2007003389A3 (de) | 2007-04-19 |
Family
ID=37562510
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2006/006430 WO2007003389A2 (de) | 2005-07-06 | 2006-07-01 | Substituierte sulfolanylpyrazole und ihre verwendung |
Country Status (2)
Country | Link |
---|---|
DE (1) | DE102005031580A1 (de) |
WO (1) | WO2007003389A2 (de) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9493437B2 (en) | 2010-08-18 | 2016-11-15 | Samumed, Llc | β- and γ-diketones and γ-hydroxyketones as Wnt/ β-catenin signaling pathway activators |
US9533976B2 (en) | 2013-02-22 | 2017-01-03 | Samumed, Llc | γ-diketones as WNT/β-catenin signaling pathway activators |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010511635A (ja) * | 2006-12-04 | 2010-04-15 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Hiv複製の阻害剤 |
RU2727039C2 (ru) | 2014-08-20 | 2020-07-17 | СЭМЬЮМЕД, ЭлЭлСи | Гамма-дикетоны для лечения и профилактики старения кожи и морщин |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995001980A1 (en) * | 1993-07-06 | 1995-01-19 | Pfizer Inc. | Bicyclic tetrahydro pyrazolopyridines |
WO2005009973A1 (en) * | 2003-06-26 | 2005-02-03 | Novartis Ag | 5-membered heterocycle-based p38 kinase inhibitors |
-
2005
- 2005-07-06 DE DE102005031580A patent/DE102005031580A1/de not_active Withdrawn
-
2006
- 2006-07-01 WO PCT/EP2006/006430 patent/WO2007003389A2/de active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995001980A1 (en) * | 1993-07-06 | 1995-01-19 | Pfizer Inc. | Bicyclic tetrahydro pyrazolopyridines |
WO2005009973A1 (en) * | 2003-06-26 | 2005-02-03 | Novartis Ag | 5-membered heterocycle-based p38 kinase inhibitors |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9493437B2 (en) | 2010-08-18 | 2016-11-15 | Samumed, Llc | β- and γ-diketones and γ-hydroxyketones as Wnt/ β-catenin signaling pathway activators |
US9533976B2 (en) | 2013-02-22 | 2017-01-03 | Samumed, Llc | γ-diketones as WNT/β-catenin signaling pathway activators |
Also Published As
Publication number | Publication date |
---|---|
DE102005031580A1 (de) | 2007-01-11 |
WO2007003389A2 (de) | 2007-01-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008113469A3 (de) | Substituierte imidazo- und triazolopyrimidine | |
ATE453642T1 (de) | Substituierte phenylaminopyrimidine | |
NL300933I2 (nl) | Letermovir | |
WO2008104306A3 (de) | Substituierte 4-aryl-1,4-dihydro-1,6-naphthyridinamide und ihre verwendung | |
WO2008155069A3 (de) | Substituierte oxazolidinone und ihre verwendung | |
WO2009068214A3 (de) | Heteroaryl-substituierte piperidine | |
WO2008046581A3 (de) | Substituierte tetrahydropyrrolopyrazin-verbindungen als inhibitoren der monoaminwiederaufnahme und deren verwendung in arzeimitteln | |
ATE416177T1 (de) | Hetaryloxy-substituierte phenylaminopyrimidine als rho-kinasehemmer | |
MX2007002470A (es) | Fenilaminotiazoles sustituidos y su uso. | |
ATE447564T1 (de) | Zwischenprodukte für die herstellung von trans-5- chlor-2-methyl-2,3,3a,12b-tetrahydro-1h-dibenzä , 3:6,7üoxepinoä4,5-cüpyrrol | |
WO2007015017A3 (fr) | Nouveaux derives de polyquinoleines et leur utilisation therapeutique | |
IL180874A0 (en) | Substituted, bicyclic 8-pyrrolidinoxanthines, method for the production thereof and their use as medicaments | |
WO2005063734A3 (de) | Substituierte thiophene | |
WO2009115252A3 (de) | Substituierte pyrazolamide und ihre verwendung | |
ATE523510T1 (de) | Substituierte 4-aryl-1,4-dihydro-1,6- naphthyridine und ihre verwendung | |
WO2006069808A3 (en) | Nitro-substituted phenyl-piperazine compounds, their preparation and use in medicaments | |
WO2006023843A3 (en) | Novel heterocycles | |
WO2006089664A3 (de) | Heterocyclylamid-substituierte imidazole | |
WO2009074247A8 (de) | Neue 2-aryl-thiazol-4-carbonsäureamid-derivate, deren herstellung und verwendung als arzneimittel | |
HK1093729A1 (en) | Substituted quinolones | |
UA86399C2 (ru) | Применение 2,5 дигидроксибензолсульфоновой кислоты для изготовления лекарства, которые применяют для лечения болезней, зависимых от ангиогенеза | |
WO2011009533A3 (de) | 17-hydroxy-17-pentafluorethyl-estra-4,9(10) -dien-11-ethinylphenyl-derivate, verfahren zu deren herstellung und deren verwendung zur behandlung von krankheiten | |
MX2009001315A (es) | Compuestos de dimetilciclobutilo substituidos, su preparación y uso en medicamentos. | |
ATE475651T1 (de) | Aryl-substituierte heterozyklen und ihre verwendung | |
WO2007009686A3 (en) | Substituted pyrazoline compounds, their preparation and use as medicaments |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06762341 Country of ref document: EP Kind code of ref document: A2 |